Quantum-Si (QSI) to Release Earnings on Thursday

Quantum-Si (NASDAQ:QSI) is expected to be releasing its earnings data after the market closes on Thursday, March 6th. Analysts expect Quantum-Si to post earnings of ($0.18) per share and revenue of $1.23 million for the quarter. Persons that are interested in registering for the company’s earnings conference call can do so using this link.

Quantum-Si Trading Up 2.1 %

Shares of NASDAQ:QSI opened at $1.49 on Thursday. Quantum-Si has a twelve month low of $0.61 and a twelve month high of $5.77. The company’s 50 day moving average is $2.23 and its 200 day moving average is $1.43. The company has a market cap of $212.64 million, a PE ratio of -2.33 and a beta of 2.70.

Insider Transactions at Quantum-Si

In other news, Director Jonathan M. Rothberg sold 3,506,267 shares of the stock in a transaction that occurred on Friday, December 27th. The stock was sold at an average price of $3.34, for a total transaction of $11,710,931.78. Following the transaction, the director now owns 1,250,000 shares in the company, valued at $4,175,000. This trade represents a 73.72 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Corporate insiders own 30.04% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages recently weighed in on QSI. HC Wainwright reiterated a “buy” rating and issued a $5.50 price target on shares of Quantum-Si in a report on Tuesday, January 14th. Canaccord Genuity Group cut their price target on shares of Quantum-Si from $1.50 to $1.00 and set a “hold” rating on the stock in a report on Wednesday, November 13th. Finally, Alliance Global Partners began coverage on shares of Quantum-Si in a report on Friday, February 7th. They issued a “buy” rating and a $3.75 price target on the stock.

About Quantum-Si

Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). The company's platform is comprised of the Platinum NGPS instrument; the Platinum Analysis Software service; and reagent kits and semiconductor chips for use with its instruments.